CBS and malignant colon neoplasm: Another study indicates that shRNA-mediated downregulation of CBS inhibits the proliferative, migrative, and invasive activities of HCT116 colon cancer cells in vitro and suppresses colon cancer growth and tumor angiogenesis in vivo [16].